OM - NASDAQ

Outset Medical, Inc.

OM·NASDAQ

$4.60

-6.3%

HealthcareMedical - Devices

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$85.27M

EPS-5.3700

P/E Ratio-0.86

Earnings Date08/05/2026

om

Income Tax Expense

Last Annual Value

718.00K

3-Year CAGR

35%

5-Year CAGR

10-Year CAGR

40%

Adjust for Inflation

Outset Medical, Inc. Competitors Analysis of Income Tax Expense

OM · NASDAQ

Company	Income Tax Expense	CAGR 3Y	CAGR 5Y	CAGR 10Y
Outset Medical, Inc. NASDAQ:OM	718.00K	11.1%	29.3%	N/A
Caribou Biosciences, Inc. NASDAQ:CRBU	-550.00K	N/A	N/A	N/A
CVRx, Inc. NASDAQ:CVRX	18.00K	-50.3%	-27.7%	N/A
Electromed, Inc. AMEX:ELMD	2.75M	44.0%	27.8%	12.7%
SANUWAVE Health, Inc. NASDAQ:SNWV	86.00K	178.1%	25.2%	-30.2%
Owens & Minor, Inc. NYSE:OMI	5.33M	N/A	-37.3%	-22.0%
Quanterix Corporation NASDAQ:QTRX	-5.12M	N/A	N/A	N/A
Inogen, Inc. NASDAQ:INGN	-632.00K	N/A	N/A	N/A
Tenaya Therapeutics, Inc. NASDAQ:TNYA	0.00	N/A	N/A	N/A
Viemed Healthcare, Inc. NASDAQ:VMD	6.39M	15.5%	13.6%	N/A
Perspective Therapeutics, Inc. AMEX:CATX	-793.00K	N/A	N/A	N/A

Outset Medical, Inc. Fair Value Envelope

OM · NASDAQ

Our analysis suggests that OM has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.6, this represents a potential HIDDEN relative to our calculated worth for Outset Medical, Inc..

HIDDEN

Intrinsic Value

Current Price: $4.6

Related Guides

Blog Categories

Continue your OM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.